In vitro assessment of human cytochrome P450

被引：109
作者：
Clarke, SE [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Drug Metab & Pharmacokinet, Welwyn Garden City AL6 9AR, Herts, England
来源：
XENOBIOTICA | 1998年 / 28卷 / 12期
关键词：
D O I：
10.1080/004982598238877
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1167 / 1202
页数：36
相关论文
共 213 条
[1]  
ABBOT MR, 1995, ISSX P, V8, P91
[2]   IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING SECONDARY OMEPRAZOLE METABOLISM [J].
ANDERSSON, T ;
MINERS, JO ;
VERONESE, ME ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (06) :597-604
[3]   DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS [J].
ANDERSSON, T ;
MINERS, JO ;
VERONESE, ME ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (02) :131-137
[4]   IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM [J].
ANDERSSON, T ;
MINERS, JO ;
VERONESE, ME ;
TASSANEEYAKUL, W ;
TASSANEEYAKUL, W ;
MEYER, UA ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (06) :521-530
[5]  
[Anonymous], BIOMETRIKA TABLES ST
[6]  
AOYAMA T, 1989, J BIOL CHEM, V264, P10388
[7]   HUMAN CDNA-EXPRESSED CYTOCHROME-P450 IA2 - MUTAGEN ACTIVATION AND SUBSTRATE-SPECIFICITY [J].
AOYAMA, T ;
GONZALEZ, FJ ;
GELBOIN, HV .
MOLECULAR CARCINOGENESIS, 1989, 2 (04) :192-198
[8]   INVITRO INHIBITION STUDIES OF TOLBUTAMIDE HYDROXYLASE-ACTIVITY OF HUMAN-LIVER MICROSOMES BY AZOLES, SULFONAMIDES AND QUINOLINES [J].
BACK, DJ ;
TJIA, JF ;
KARBWANG, J ;
COLBERT, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (01) :23-29
[9]   KETOCONAZOLE AND SULFAPHENAZOLE AS THE RESPECTIVE SELECTIVE INHIBITORS OF P4503A AND 2C9 [J].
BALDWIN, SJ ;
BLOOMER, JC ;
SMITH, GJ ;
AYRTON, AD ;
CLARKE, SE ;
CHENERY, RJ .
XENOBIOTICA, 1995, 25 (03) :261-270
[10]  
BALL SE, 1992, DRUG METAB DISPOS, V20, P56
12345678910